We've Built and Sold
This Business Before.
Same team. Same technology approach. Same surgeon relationships. New opportunity.
The Opportunity
78% of orthopedic surgeons want surgical guidance technology. Only 13% can access it.
The barrier is economics, not technology. $1.3M surgical robots exclude most facilities. The fastest-growing segment of orthopedic care—ambulatory surgery centers—cannot afford current solutions.
Zooly eliminates the barrier. AI-guided instruments deliver robotic-level precision with per-procedure pricing. No capital equipment. No infrastructure. No exclusion.
Leadership
Robert Winder
3x orthopedic technology entrepreneur. Robert's previous company, MUVR, developed IMU sensor technology for surgical guidance. Exactech (owned by TPG) acquired MUVR in 2020. Zooly applies the same sensor approach with AI-driven intervention.
Prudhvi Chinimilli, Ph.D.
Ph.D. in wearable sensors and assistive robotics for healthcare. Previously at MUVR, where he developed the core IMU technology acquired by Exactech. Deep expertise in surgical motion tracking systems.
Moritz Sharabianlou Korth, M.D.
Joint reconstruction specialist with hands-on surgical experience. Medical device development expert. Dr. Korth ensures our product solves real problems surgeons face daily.
Advisors
Derek F. Amanatullah, M.D., Ph.D.
Alexander Sah, M.D.
John Costouros, M.D.
Why We Win
Proven Technology Model
Our IMU sensor approach powered MUVR's successful exit. Zooly adds AI-driven intervention—the system stops your tool before errors occur.
Established Surgeon Network
4 surgeon advisors with equity stakes. 9 surgeons committed to implement on Day 1. Stanford and NYU leadership relationships.
Clear Regulatory Path
FDA 510(k) pathway through established predicates. OrthAlign and Navbit cleared the path. We follow with enhanced capability.
Capital-Efficient Model
Per-procedure pricing with zero upfront investment. Facilities generate value from procedure one—no capital equipment required.
Milestones
Achieved
- ✓Working prototype complete
- ✓Real-time motion tracking validated
- ✓Advisory board assembled
- ✓9 surgeons committed to implementation
- ✓3 patents filed
2026 Targets
- →FDA 510(k) clearance
- →First 100 surgeons onboarded
- →1,000+ procedures
- →Series A readiness